John F. Crowley - 12 Jul 2021 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role: Chairman & CEO, Director
Signature: /s/ Christian Formica, Attorney-in-Fact
Issuer symbol: FOLD
Transactions as of: 12 Jul 2021
Net transactions value: -$138,652
Form type: 4
Filing time: 14 Jul 2021, 21:08:27 UTC
Previous filing: 25 Jun 2021
Next filing: 09 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FOLD	Common Stock	Sale	$138,652	-14,885	-1.7%	$9.31	862,345	12 Jul 2021	Direct	F1, F2
holding	FOLD	Common Stock						64,895	12 Jul 2021	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2	This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $9.17 to $9.59 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $9.17 to $9.59 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.